Altamira Therapeutics Ltd. Increase Decrease In Cash And Cash Equivalents Discontinued Operations
Altamira Therapeutics Ltd. (CYTOF) reported Increase Decrease In Cash And Cash Equivalents Discontinued Operations of -CHF 35.79 thousand for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations · last filed 2025-04-30
CHF
| Period end | Increase Decrease In Cash And Cash Equivalents Discontinued Operations 12 month |
|---|---|
| 2023-12-31 | -35.79K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | -177.04K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | -728.59K CHF 20-F/A · filed 2024-04-22 |
USD
| Period end | Increase Decrease In Cash And Cash Equivalents Discontinued Operations 12 month |
|---|---|
| 2023-12-31 | -$39.83K 20-F · filed 2025-04-30 |
| 2022-12-31 | -$185.38K 20-F · filed 2025-04-30 |